5 ms·
Other antibody studies have consistently found similar results to the Stanford one. The Stanford numbers are very high - most have found closer to 20-30x report
by SpicyLemonZest 7y ago
Other antibody studies have consistently found similar results to the Stanford one. The Stanford numbers are very high - most have found closer to 20-30x reported cases than 50-85x - but it's virtually guaranteed that a huge fraction New Yorkers have C19 antibodies today. I'd be pretty surprised if it's less than 20%.
- watwut 7y agoI would say that "20-30x reported cases" is not similar to "50-85x reported cases". Those are massively different numbers.
- SpicyLemonZest 7y agoThey are! I don't mean to deny that, there's a large discrepancy which Stanford and other researchers in Santa Clara County should work to resolve. But when newspapers and governments report numbers that are off by at least a factor of 20, a factor of 2-4 isn't the most pressing concern.
- watwut 7y agoThey report people who tested positive as cases. The testing is quite limited and almost never done for people without symptoms. It is typically done for people with strong symptoms. Existence of asymptomatic infected people is widely known at this point. So I would expect undereporting in cases. So the additional 2-4 factor from study that is supposed to figure out underreporting is actually big deal. Because reported cases where never assumed to be everyone sick (or infected) and I never seen anyone pretend they represent all infected people. Meanwhile, this study presents itself as estimate of immune people in population.
- SpicyLemonZest 7y agoI've never seen anyone assert the specific claim "reported cases capture everyone infected". But I've regularly seen people claim that we know it's a very deadly disease because the number of deaths is 1-2% the number of reported cases, or claim that there's some burden of proof which other studies have to give to justify deviating from the reported count.
- kgwgk 7y agoThe number of deaths is 0.1-0.2% of the population of NYC. An infection fatality rate of 1% is plausible (corresponds to a 10-20% infection rate). The case fatality rate from confirmed cases is 7%, not 1-2%.
- ineedasername 7y agoThis is why you don't compare the current situation tothe known fatality rates of another pandemic for which the dust has settled and we already know everything. A better (not perfect) method is the CFR, where you compare the current CFR to the CFR of the other pandemic when that pandemic was ongoing. If we take something like H1N1, the CFR during that pandemic was significantly lower than what we face right now [0] and was highly dependent on healthcare infrastructure. We're getting CFR rates, e.g. in NYC, far in excess of those seen in even the worst places with H1N1. [0] https://www.cebm.net/covid-19/global-covid-19-case-fatality-rates/ https://www.cebm.net/covid-19/global-covid-19-case-fatality-...
- watwut 7y ago1.) Case fatality ratio, alias CFR, alias the number of deaths per the number of reported cases is NOT 1-2%. And pretty much never was. It was much higher. 2.) We knew it is deadly from observing meltdown in Italy and from observing China. Currently from observing New York. 3.) When you complain that reported cases "underreport" what exactly are you claiming? And what exact unfair burden of proof is there on this scientific study?
- twomoretime 7y agoIf the point is that cases are underreported, there isn't much of a difference between 20x, 30x, and 80x. The post was likely emphasizing that other studies have found even crazier numbers so 20-30x isn't unreasonable.
- kgwgk 7y ago20% would be 13x not 20-30x or 50-85x.
- SpicyLemonZest 7y agoYou're right, my mental math was off. I'll call it a margin of error in case something's special about New York.
- DennisP 7y agoMany of the other studies have also been with populations that had relatively low numbers infected. Fortunately New York is about to do broad antibody testing themselves, so we should get better answers soon.
- deleted 7y ago[deleted]
- SpicyLemonZest 7y agoAlmost every claim that's ever been made about the coronavirus hasn't passed peer review and has been criticized heavily. If you only accept non-controversial peer-reviewed information, you're pretty much going to be stuck with "COVID-19 is a new pandemic respiratory virus".
- sjg007 7y agoWe don't know if these antibody tests are specific for covid-19 only or in fact for any coronavirus. We don't know if they randomly test positive either due to something else. There are a lot of unknowns. These antibody tests are not FDA approved.
- SpicyLemonZest 7y agoWe lost a month at the beginning of this pandemic waiting for FDA approval of the tests confirming coronavirus was spreading in the US. I am unconvinced that this approval offered any value at all, and we can't afford to lose another month waiting to see how far it's spread.
- sjg007 7y agoWell then you are making two mistakes.
- ineedasername 7y agoYour statement amounts to "we have to do something. This is something. Therefore we have to do it." Doing the wrong thing can be extremely dangerous in this situation. Consciously choosing to wait until you have greater certainty that the action taken is correct isn't the same as inaction, not when the downside risks of getting it wrong are so high.
- SpicyLemonZest 7y agoI disagree that theorizing and gathering data can be extremely dangerous in this situation. If we're worried the Stanford study is flawed, the right response is to urgently do more studies, not sit on our hands waiting for some ponderous FDA approval process.
- ineedasername 7y agoThere's a certain limited amount of qualified research capacity representing a bottleneck. So, urgently doing more studies to refute one that has flaws and bias by the author isn't the right type of action to take if it will take resources from other, more productive endeavors. Theorizing and gathering data is fine; going on to write a WSJ op-ed pushing it in a way you hope will influence policy goes a far step beyond proper scientific research protocols.
- longtimegoogler 7y agoThe point is that given the accuracy of the tests in the Stanford study all 50 positives could have been false positives. In other words, they don't have the testing power to discern if it is even 5x. Until about 5% of the population is infected the current antibody tests are useless.